[1]
|
A. Maxmen, “The Hard Facts,” Nature, Vol. 485, No. 7400, 2012, pp. S50-S51. doi:10.1038/485S50a
|
[2]
|
P. Stone, A. Richardson, E. Ream, et al., “Cancer-Related Fatigue: Inevitable, Unimportant and Untreatable? Results of a Multi-Centre Patient Survey,” Annals of Oncology, Vol 11, No. 8, 2000, pp. 971-975. doi:10.1023/A:1008318932641
|
[3]
|
P. Servaes, M. F. M. Gielissen, S. Verhagen, et al., “The Course of Severe Fatigue in Disease-Free Breast Cancer Patients: A Longitudinal Study,” Psycho-Oncology, Vol 16, No. 9, 2007, pp. 787-795. doi:10.1002/pon.1120
|
[4]
|
A. C. G. Cavalli Kluthcovsky, A. A. Urbanetz, D. S. de Carvalho, et al., “Fatigue after Treatment in Breast Cancer Survivors: Prevalence, Determinants and Impact on Health-Related Quality of Life,” Support Care Cancer, Vol. 20, No. 8, 2012, pp. 1901-1909. doi:10.1007/s00520-011-1293-7
|
[5]
|
V. Mock, C. Frangakis, N. E. Davidson, et al., “Exercise Manages Fatigue during Breast Cancer Treatment: A Randomized Controlled Trial,” Psycho-Oncology, Vol. 14, No. 6, 2005, pp. 464-477. doi:10.1002/pon.863
|
[6]
|
K. M. Mustian, G. R. Morrow, J. K. Carroll, et al., “Integrative Nonpharmacologic Behavioral Interventions for the Management of Cancer-Related Fatigue,” Oncologist, Vol 12, Suppl. 1, 2007, pp. 52-67. doi:10.1634/theoncologist.12-S1-52
|
[7]
|
S. B. Yellen, D. F. Cella, K. Webster, et al., “Measuring Fatigue and Other Anemia-Related Symptoms with the Functional Assessment of Cancer Therapy (FACT) Measurement System,” Journal of Pain and Symptom Management, Vol 13, No. 2, 1997, pp. 63-74. doi:10.1016/S0885-3924(96)00274-6
|
[8]
|
R. H. Dunstan, D. L. Sparkes, M. M. Macdonald, et al., “Altered Amino Acid Homeostasis and the Development of Fatigue by Breast Cancer Radiotherapy Patients: A Pilot Study,” Clinical Biochemistry, Vol. 44, No. 2-3, 2011, pp. 208-215. doi:10.1016/j.clinbiochem.2010.10.002
|
[9]
|
G. Lepage and C. C. Roy, “Direct Transesterification of All Classes of Lipids in a One-Step Reaction,” The Journal of Lipid Research, Vol. 27, 1, 1986, pp. 114-120.
|
[10]
|
J. Trygg and S. Wold, “Orthogonal Projections to Latent Structures (O-PLS),” Journal of Chemometrics, Vol. 16, No. 3, 2002, pp. 119-128. doi:10.1002/cem.695
|
[11]
|
J. E. Jackson, “A User’s Guide to Principal Components,” Wiley, New York, 1991. doi:10.1002/0471725331
|
[12]
|
S. Wold, “Cross-Validatory Estimation of the Number of Components in Factor and Principal Components Models,” Technometrics, Vol. 20, No. 4, 1978. pp. 397-405. doi:10.1080/00401706.1978.10489693
|
[13]
|
C. Cleeland and S. Wang, “Measuring and Understanding Fatigue,” Oncology, Vol. 13, No. 11A, 1999, pp. 91-97.
|
[14]
|
C. Wratten, J. Kilmurray, S. Nash, et al., “Fatigue during Breast Radiotherapy and Its Relationship to Biological Factors,” International Journal of Radiation Oncology, Biology and Physics, Vol. 59, No. 1, 2004, pp. 160-167.doi:10.1016/j.ijrobp.2003.10.008
|
[15]
|
E. M. A. Smets, M. R. M. Visser, A. F. M. N. Willems-Groot, et al., “Fatigue and Radiotherapy: (A) Experience in Patients Undergoing Treatment,” British Journal of Cancer, Vol. 78, No. 7, 1998, pp. 899-906. doi:10.1038/bjc.1998.599
|
[16]
|
H. Geinitz, F. B. Zimmermann, R. Thamm, et al., “Fatigue in Patients with Adjuvant Radiation Therapy for Breast Cancer: Long-Term Follow-Up,” Journal of Cancer Research and Clinical Oncology, Vol. 130, No. 6, 2004, pp. 327-333. doi:10.1007/s00432-003-0540-9
|
[17]
|
R. Morant, “Asthenia: An Important Symptom in Cancer Patients,” Cancer Treatment Reviews, Vol. 22, Suppl. A, 1996, pp. 117-122. doi:10.1016/S0305-7372(96)90073-0
|
[18]
|
J. E. Bower, P. A. Ganz, K. A. Desmond, et al., “Fatigue in Breast Cancer Survivors: Occurrence, Correlates, and Impact on Quality of Life,” Journal of Clinical Oncology, Vol. 18, No. 4, 2000, pp. 743-753.
|
[19]
|
S. Haghighat, M. E. Akbari, K. Holakouei, et al., “Factors Predicting Fatigue in Breast Cancer Patients,” Support Care Cancer, Vol. 11, No. 8, 2003. pp. 533-538. doi:10.1007/s00520-003-0473-5
|
[20]
|
R. Haque, M. U. Yood, A. M. Geiger, et al., “Long-Term Safety of Radiotherapy and Breast Cancer Laterality in Older Survivors,” Cancer Epidemiology, Biomarkers & Prevention, Vol. 20, No. 10, 2011, pp. 2120-2126.doi:10.1158/1055-9965.EPI-11-0348
|